Laura Esserman, Principal Investigator at The WISDOM Study, shared a post on LinkedIn:
“We are looking forward to important changes in 2026 – like implementing the WISDOM model of personalized screening! And personalized oncology care in RECAST (evaluation of active surveillance for DCIS) and I-SPY2.2 (personalized treatment for high-risk breast cancer based on biology and response)!
And of course, we are looking forward to RISE UP for Breast Cancer and Women’s Health, our upcoming conference: February 19-21, 2026! Hoping to make everyone’s new year a happier and healthier one.”
More posts featuring Laura Esserman.